# Safety and Tolerability Study of rBet v1 SLIT Tablets

> **NCT00889460** · PHASE1 · COMPLETED · sponsor: **Stallergenes Greer** · enrollment: 55 (actual)

## Conditions studied

- Birch Pollen-Related Rhinoconjunctivitis
- Rhinitis, Allergic, Seasonal

## Interventions

- **BIOLOGICAL:** rBet v 1
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00889460
- **Lead sponsor:** Stallergenes Greer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2009-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00889460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00889460, "Safety and Tolerability Study of rBet v1 SLIT Tablets". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00889460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*